Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-25 Sale | 2022-04-27 4:34 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 8,694 | $6.0399 | $52,511 | 318,147 (Direct) | View |
| 2022-04-20 Sale | 2022-04-22 8:04 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 1,289 | $6.0128 | $7,751 | 326,841 (Direct) | View |
| 2022-04-11 Sale | 2022-04-13 6:10 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 32,849 | $6.8694 | $225,654 | 328,130 (Direct) | View |
| 2022-04-06 Sale | 2022-04-08 4:21 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 2,181 | $7.5458 | $16,457 | 360,979 (Direct) | View |
| 2022-04-01 Sale | 2022-04-05 5:01 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 3,800 | $7.7168 | $29,324 | 363,160 (Direct) | View |
| 2022-03-30 Sale | 2022-04-01 5:36 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 300 | $7.52 | $2,256 | 366,960 (Direct) | View |
| 2022-03-25 Sale | 2022-03-29 4:29 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 10,300 | $7.5431 | $77,694 | 367,260 (Direct) | View |
| 2022-03-21 Sale | 2022-03-24 5:32 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 4,800 | $7.5192 | $36,092 | 377,560 (Direct) | View |
| 2022-03-17 Sale | 2022-03-21 5:47 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 3,604 | $7.5268 | $27,126 | 382,360 (Direct) | View |
| 2022-03-14 Sale | 2022-03-16 4:29 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 1,500 | $6.9727 | $10,459 | 385,964 (Direct) | View |
| 2022-03-09 Sale | 2022-03-14 4:18 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 2,822 | $7.0275 | $19,832 | 387,464 (Direct) | View |
| 2022-03-04 Sale | 2022-03-08 4:59 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 14,504 | $7.1666 | $103,945 | 390,286 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:53 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 27,593 | $7.4367 | $205,201 | 404,790 (Direct) | View |
| 2022-02-24 Sale | 2022-02-28 7:13 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 13,752 | $7.5026 | $103,176 | 432,383 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 5:58 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 38,297 | $7.7926 | $298,434 | 446,135 (Direct) | View |
| 2022-02-15 Sale | 2022-02-17 5:39 pm | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 47,502 | $8.0798 | $383,808 | 484,432 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-04 Disposition | 2024-06-04 5:31 pm | N/A N/A | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 4,236,480 | $0 | 0 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-05 08:41 am | N/A 2034-01-04 | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 512,600 | $0 | 512,600 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-09 06:46 am | N/A 2033-01-04 | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:40 pm | N/A 2032-02-01 | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 406,600 | $0 | 406,600 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 9:10 pm | N/A 2031-02-03 | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 336,000 | $0 | 336,000 (Direct) | View |
| 2020-02-06 Option Award | 2020-06-30 06:41 am | N/A 2030-01-10 | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 753,017 | $0 | 753,017 (Direct) | View |
Ownership | 2020-06-25 8:02 pm | N/A N/A | Fusion Pharmaceuticals Inc. | FUSN | Valliant John Chief Executive Officer | 0 | $0 | 2,115,578 (Indirect) | View |